ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 262 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $378,704 | -45.1% | 18,172 | -36.9% | 0.18% | -44.4% |
| Q2 2023 | $689,544 | -34.1% | 28,791 | -48.2% | 0.32% | -63.0% |
| Q1 2023 | $1,045,903 | +16.0% | 55,574 | -1.8% | 0.85% | +59.3% |
| Q4 2022 | $901,359 | +3.4% | 56,618 | +6.2% | 0.54% | +7.4% |
| Q3 2022 | $872,000 | +55.2% | 53,318 | +33.6% | 0.50% | +46.9% |
| Q2 2022 | $562,000 | -32.0% | 39,900 | +17.0% | 0.34% | -35.4% |
| Q1 2022 | $826,000 | +93.0% | 34,116 | +105.6% | 0.52% | +65.1% |
| Q1 2021 | $428,000 | -44.2% | 16,590 | +15.7% | 0.32% | -35.1% |
| Q4 2020 | $767,000 | +49.5% | 14,344 | +15.4% | 0.49% | +31.0% |
| Q3 2020 | $513,000 | +20.4% | 12,429 | +41.3% | 0.37% | +5.9% |
| Q2 2020 | $426,000 | – | 8,794 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |